BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12538419)

  • 21. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients.
    Colín-Ramírez E; Castillo-Martínez L; Orea-Tejeda A; Asensio Lafuente E; Torres Villanueva F; Rebollar González V; Narváez David R; Dorantes García J
    Clin Nutr; 2006 Oct; 25(5):746-57. PubMed ID: 16698139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
    van der Meer P; Lipsic E; Westenbrink BD; van de Wal RM; Schoemaker RG; Vellenga E; van Veldhuisen DJ; Voors AA; van Gilst WH
    Circulation; 2005 Sep; 112(12):1743-7. PubMed ID: 16172283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions.
    Abramov D; Cohen RS; Katz SD; Mancini D; Maurer MS
    Am J Cardiol; 2008 Oct; 102(8):1069-72. PubMed ID: 18929711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart failure and anemia: Effects on prognostic variables.
    Cattadori G; Agostoni P; Corrà U; Sinagra G; Veglia F; Salvioni E; Bonomi A; La Gioia R; Scardovi AB; Ferraironi A; Emdin M; Metra M; Di Lenarda A; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Caravita S; Magrì D; Lombardi C; Frigerio M; Oliva F; Girola D; Mezzani A; Farina S; Mapelli M; Scrutinio D; Pacileo G; Apostolo A; Iorio A; Paolillo S; Filardi PP; Gargiulo P; Bussotti M; Marchese G; Correale M; Badagliacca R; Sciomer S; Palermo P; Contini M; Giannuzzi P; Battaia E; Cicoira M; Clemenza F; Minà C; Binno S; Passino C; Piepoli MF;
    Eur J Intern Med; 2017 Jan; 37():56-63. PubMed ID: 27692931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia in heart failure: pathophysiologic insights and treatment options.
    Terrovitis JV; Anastasiou-Nana M; Kaldara E; Drakos SG; Nanas SN; Nanas JN
    Future Cardiol; 2009 Jan; 5(1):71-81. PubMed ID: 19371205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. True Anemia-Red Blood Cell Volume Deficit-in Heart Failure: A Systematic Review.
    Montero D; Lundby C; Ruschitzka F; Flammer AJ
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28455293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.
    Mancini DM; Katz SD; Lang CC; LaManca J; Hudaihed A; Androne AS
    Circulation; 2003 Jan; 107(2):294-9. PubMed ID: 12538431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries).
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Peller M; Balsam P; Marchel M; Crespo-Leiro MG; Maggioni AP; Jankowska EA; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2017 Jun; 119(12):2021-2029. PubMed ID: 28434647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaemia in chronic heart failure: more awareness is required.
    Pisaniello AD; Wong DT; Kajani I; Robinson K; Shakib S
    Intern Med J; 2013 Sep; 43(9):999-1004. PubMed ID: 23692411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
    J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anemia and new-onset congestive heart failure in the general Medicare population.
    Sandgren PE; Murray AM; Herzog CA; Solid CA; Gilbertson DT; Collins AJ; Foley RN
    J Card Fail; 2005 Mar; 11(2):99-105. PubMed ID: 15732028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The statistical analysis of prevalence of anemia in patients with chronic heart failure].
    Uskach TM; Kochetov AG; Tereshchenko SN
    Kardiologiia; 2011; 51(1):11-7. PubMed ID: 21626796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements.
    Drevon L; Maslah N; Soret-Dulphy J; Dosquet C; Ravdan O; Vercellino L; Belkhodja C; Parquet N; Brignier AC; Schlageter MH; Cassinat B; Kiladjian JJ; Chomienne C; Giraudier S
    Haematologica; 2021 Apr; 106(4):1167-1171. PubMed ID: 32586907
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction.
    Kosiborod M; Krumholz HM; Jones PG; Pitt B; Spertus JA
    J Card Fail; 2008 Feb; 14(1):27-34. PubMed ID: 18226770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood volume analysis can distinguish true anemia from hemodilution in critically ill patients.
    Van PY; Riha GM; Cho SD; Underwood SJ; Hamilton GJ; Anderson R; Ham LB; Schreiber MA
    J Trauma; 2011 Mar; 70(3):646-51. PubMed ID: 21610355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure.
    Kourea K; Parissis JT; Farmakis D; Paraskevaidis I; Panou F; Filippatos G; Kremastinos DT
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):365-9. PubMed ID: 18525396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
    Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.